Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–8 of 8 results
Advanced filters: Author: Stephan Windecker Clear advanced filters

  • An inflammatory process may increase the risk of arrhythmias after transcatheter aortic valve replacement. Here, the authors show that periprocedural treatment with colchicine may reduce the incidence of new-onset arrhythmias and subclinical leaflet thrombosis after transcatheter aortic valve replacement.

    • Christoph Ryffel
    • Jonas Lanz
    • Thomas Pilgrim
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-11

  • In light of the recent furore over late stent thrombosis and drug-eluting stents, Drs Stephan Windecker and Peter Jüni present their thorough review of the benefits and risks of first-generation sirolimus-eluting and paclitaxel-eluting stents, providing practical advice on the use of these devices in different patient groups.

    • Stephan Windecker
    • Peter Jüni
    Reviews
    Nature Clinical Practice Cardiovascular Medicine
    Volume: 5, P: 316-328

  • Coronary revascularization has a prominent role in the management of chronic, stable coronary artery disease, but decision-making guided by angiography alone for identifying haemodynamically relevant lesions can be challenging. The DEFER study now demonstrates favourable 15-year outcomes after deferral of revascularization in angiographically relevant, but functionally nonsignificant, coronary lesions.

    • Konstantinos C. Koskinas
    • Stephan Windecker
    News & Views
    Nature Reviews Cardiology
    Volume: 13, P: 7-8

  • Anomalous aortic origin of the coronary artery (AAOCA) is a rare cardiac condition that is often falsely classified in routine coronary CT angiography (CCTA). Here the authors developed an AI-based tool was developed to detect and classify AAOCA in CT images with high accuracy to improve management of this condition.

    • Isaac Shiri
    • Giovanni Baj
    • Christoph Gräni
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-11

  • The evolution of stent design has reduced the incidence of stent thrombosis, meaning that the duration of dual antiplatelet therapy after percutaneous coronary intervention (PCI) might be shortened. In this Review, the authors describe the current evidence base and ongoing clinical trials into the use of P2Y12 inhibitor monotherapy after PCI.

    • Davide Capodanno
    • Usman Baber
    • Dominick J. Angiolillo
    Reviews
    Nature Reviews Cardiology
    Volume: 19, P: 829-844

  • In this Review, a panel of leading experts in antithrombotic pharmacotherapy discuss the principles guiding the role of acetylsalicylic acid (aspirin)-free strategies in the prevention and management of cardiovascular disease, along with their implications for clinical trial design and development.

    • Davide Capodanno
    • Roxana Mehran
    • Dominick J. Angiolillo
    Reviews
    Nature Reviews Cardiology
    Volume: 15, P: 480-496

  • In this Review, Angiolillo and colleagues discuss the latest evidence and updates on bleeding avoidance strategies in patients undergoing percutaneous coronary intervention, including risk stratification, timing of revascularization, pretreatment with antiplatelet agents, selection of vascular access, choice of coronary stents and antithrombotic treatment regimens.

    • Davide Capodanno
    • Deepak L. Bhatt
    • Dominick J. Angiolillo
    Reviews
    Nature Reviews Cardiology
    Volume: 19, P: 117-132